This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-107 | ACTG2 | 1.31 | 0 | -5.39 | 0 | miRanda | -1.98 | 0 | NA | |
2 | hsa-miR-125a-5p | ACTG2 | 0.6 | 0.01023 | -5.39 | 0 | miRanda | -0.51 | 0.00044 | NA | |
3 | hsa-miR-129-5p | ACTG2 | -0.52 | 0.22258 | -5.39 | 0 | miRanda | -0.33 | 3.0E-5 | NA | |
4 | hsa-miR-193a-3p | ACTG2 | 1.6 | 0 | -5.39 | 0 | miRanda | -0.29 | 0.00696 | NA | |
5 | hsa-miR-590-3p | ACTG2 | 2.59 | 0 | -5.39 | 0 | miRanda | -1.27 | 0 | NA | |
6 | hsa-miR-107 | MYH11 | 1.31 | 0 | -6.47 | 0 | miRanda | -2.04 | 0 | NA | |
7 | hsa-miR-129-5p | MYH11 | -0.52 | 0.22258 | -6.47 | 0 | miRanda | -0.36 | 3.0E-5 | NA | |
8 | hsa-miR-146b-5p | MYH11 | 1.76 | 0 | -6.47 | 0 | miRanda | -0.22 | 0.04348 | NA | |
9 | hsa-miR-193a-3p | MYH11 | 1.6 | 0 | -6.47 | 0 | PITA; miRanda | -0.59 | 0 | NA | |
10 | hsa-miR-19a-3p | MYH11 | 3.42 | 0 | -6.47 | 0 | MirTarget | -1.32 | 0 | NA | |
11 | hsa-miR-19b-3p | MYH11 | 2.5 | 0 | -6.47 | 0 | MirTarget | -1.73 | 0 | NA | |
12 | hsa-miR-342-5p | MYH11 | 1.75 | 0 | -6.47 | 0 | miRNATAP | -1.11 | 0 | NA | |
13 | hsa-miR-34c-5p | MYH11 | 2.07 | 0 | -6.47 | 0 | miRanda | -0.46 | 0 | NA | |
14 | hsa-miR-3614-5p | MYH11 | 2.18 | 0 | -6.47 | 0 | miRNATAP | -0.71 | 0 | NA | |
15 | hsa-miR-421 | MYH11 | 1.18 | 1.0E-5 | -6.47 | 0 | miRanda | -0.98 | 0 | NA | |
16 | hsa-miR-491-5p | MYH11 | 0.62 | 0.04183 | -6.47 | 0 | miRanda | -0.83 | 0 | NA | |
17 | hsa-miR-590-5p | MYH11 | 3.18 | 0 | -6.47 | 0 | miRanda | -1.49 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CHROMOSOME ORGANIZATION | 55 | 1009 | 1.852e-16 | 8.618e-13 |
2 | MITOTIC CELL CYCLE | 46 | 766 | 2.184e-15 | 5.081e-12 |
3 | CELL CYCLE PROCESS | 54 | 1081 | 1.401e-14 | 2.174e-11 |
4 | CELL CYCLE | 60 | 1316 | 2.212e-14 | 2.573e-11 |
5 | MITOTIC NUCLEAR DIVISION | 30 | 361 | 6.369e-14 | 5.927e-11 |
6 | ORGANELLE FISSION | 34 | 496 | 3.346e-13 | 2.595e-10 |
7 | MICROTUBULE BASED PROCESS | 34 | 522 | 1.414e-12 | 9.397e-10 |
8 | CELL DIVISION | 30 | 460 | 3.089e-11 | 1.797e-08 |
9 | MITOTIC SISTER CHROMATID SEGREGATION | 14 | 91 | 1.158e-10 | 5.987e-08 |
10 | MICROTUBULE CYTOSKELETON ORGANIZATION | 25 | 348 | 1.964e-10 | 9.14e-08 |
11 | CHROMATIN MODIFICATION | 31 | 539 | 3.288e-10 | 1.391e-07 |
12 | CHROMATIN REMODELING | 16 | 150 | 1.452e-09 | 5.63e-07 |
13 | REGULATION OF ORGANELLE ORGANIZATION | 47 | 1178 | 1.862e-09 | 6.189e-07 |
14 | NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 25 | 387 | 1.786e-09 | 6.189e-07 |
15 | MICROTUBULE BASED MOVEMENT | 18 | 205 | 3.201e-09 | 9.93e-07 |
16 | REGULATION OF MICROTUBULE BASED PROCESS | 19 | 243 | 7.961e-09 | 2.315e-06 |
17 | NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 18 | 221 | 1.05e-08 | 2.875e-06 |
18 | CHROMATIN ORGANIZATION | 32 | 663 | 1.223e-08 | 3.162e-06 |
19 | DNA METABOLIC PROCESS | 34 | 758 | 2.538e-08 | 6.215e-06 |
20 | REGULATION OF CYTOSKELETON ORGANIZATION | 26 | 502 | 7.772e-08 | 1.808e-05 |
21 | CELL CYCLE PHASE TRANSITION | 18 | 255 | 9.5e-08 | 2.103e-05 |
22 | SISTER CHROMATID SEGREGATION | 15 | 176 | 9.945e-08 | 2.103e-05 |
23 | ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 11 | 94 | 2.145e-07 | 4.026e-05 |
24 | ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS II | 11 | 94 | 2.145e-07 | 4.026e-05 |
25 | METAPHASE PLATE CONGRESSION | 8 | 42 | 2.163e-07 | 4.026e-05 |
26 | CHROMOSOME SEGREGATION | 18 | 272 | 2.495e-07 | 4.465e-05 |
27 | RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ER | 10 | 77 | 2.859e-07 | 4.761e-05 |
28 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 30 | 684 | 2.865e-07 | 4.761e-05 |
29 | PROTEIN COMPLEX SUBUNIT ORGANIZATION | 49 | 1527 | 7.287e-07 | 0.0001169 |
30 | MITOTIC SPINDLE ORGANIZATION | 9 | 69 | 1.093e-06 | 0.0001695 |
31 | DNA REPAIR | 23 | 480 | 1.707e-06 | 0.0002562 |
32 | COVALENT CHROMATIN MODIFICATION | 19 | 345 | 1.878e-06 | 0.0002731 |
33 | PROTEIN COMPLEX BIOGENESIS | 39 | 1132 | 2.137e-06 | 0.0002924 |
34 | PROTEIN COMPLEX ASSEMBLY | 39 | 1132 | 2.137e-06 | 0.0002924 |
35 | NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY | 13 | 170 | 2.435e-06 | 0.0003238 |
36 | MITOTIC SPINDLE ASSEMBLY | 7 | 41 | 2.753e-06 | 0.0003371 |
37 | MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 7 | 41 | 2.753e-06 | 0.0003371 |
38 | NUCLEAR CHROMOSOME SEGREGATION | 15 | 228 | 2.72e-06 | 0.0003371 |
39 | REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 13 | 178 | 4.055e-06 | 0.0004838 |
40 | CHROMOSOME LOCALIZATION | 8 | 61 | 4.188e-06 | 0.0004872 |
41 | MACROMOLECULAR COMPLEX ASSEMBLY | 44 | 1398 | 4.786e-06 | 0.0005432 |
42 | DNA CONFORMATION CHANGE | 16 | 273 | 5.627e-06 | 0.0006234 |
43 | CYTOSKELETON ORGANIZATION | 31 | 838 | 6.371e-06 | 0.0006894 |
44 | REGULATION OF PROTEIN COMPLEX DISASSEMBLY | 14 | 217 | 7.33e-06 | 0.0007579 |
45 | CELLULAR RESPONSE TO DNA DAMAGE STIMULUS | 28 | 720 | 7.316e-06 | 0.0007579 |
46 | SPINDLE ASSEMBLY | 8 | 70 | 1.191e-05 | 0.001205 |
47 | REGULATION OF MITOTIC CELL CYCLE | 21 | 468 | 1.32e-05 | 0.001307 |
48 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 13 | 199 | 1.36e-05 | 0.001318 |
49 | ATP DEPENDENT CHROMATIN REMODELING | 8 | 74 | 1.803e-05 | 0.001712 |
50 | REGULATION OF CELL DIVISION | 15 | 272 | 2.262e-05 | 0.002105 |
51 | CYTOSKELETON DEPENDENT CYTOKINESIS | 6 | 39 | 2.702e-05 | 0.002465 |
52 | REGULATION OF CELL CYCLE | 32 | 949 | 2.859e-05 | 0.002559 |
53 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 14 | 247 | 3.137e-05 | 0.002754 |
54 | MICROTUBULE DEPOLYMERIZATION | 4 | 13 | 3.534e-05 | 0.00299 |
55 | DNA GEOMETRIC CHANGE | 8 | 81 | 3.505e-05 | 0.00299 |
56 | PEPTIDYL AMINO ACID MODIFICATION | 29 | 841 | 4.637e-05 | 0.003853 |
57 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 49 | 1784 | 4.958e-05 | 0.004048 |
58 | CELL CYCLE G1 S PHASE TRANSITION | 9 | 111 | 5.541e-05 | 0.00437 |
59 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 9 | 111 | 5.541e-05 | 0.00437 |
60 | CELL CYCLE G2 M PHASE TRANSITION | 10 | 138 | 5.642e-05 | 0.004376 |
61 | REGULATION OF CELL CYCLE PROCESS | 22 | 558 | 5.859e-05 | 0.004469 |
62 | MITOTIC CELL CYCLE CHECKPOINT | 10 | 139 | 5.998e-05 | 0.004502 |
63 | HISTONE H2A ACETYLATION | 4 | 15 | 6.585e-05 | 0.004863 |
64 | CELLULAR RESPONSE TO STRESS | 44 | 1565 | 7.421e-05 | 0.005395 |
65 | ORGANELLE LOCALIZATION | 18 | 415 | 8.47e-05 | 0.006063 |
66 | CENTROMERE COMPLEX ASSEMBLY | 6 | 48 | 9.048e-05 | 0.006379 |
67 | ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 11 | 177 | 9.79e-05 | 0.006799 |
68 | MITOTIC CYTOKINESIS | 5 | 31 | 0.0001026 | 0.006817 |
69 | PEPTIDYL SERINE MODIFICATION | 10 | 148 | 0.0001016 | 0.006817 |
70 | MISMATCH REPAIR | 5 | 31 | 0.0001026 | 0.006817 |
71 | HISTONE H4 ACETYLATION | 6 | 50 | 0.0001142 | 0.007483 |
72 | DNA RECOMBINATION | 12 | 215 | 0.0001328 | 0.008579 |
73 | GOLGI VESICLE TRANSPORT | 15 | 319 | 0.0001373 | 0.008752 |
74 | SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 9 | 127 | 0.0001569 | 0.009732 |
75 | CELLULAR COMPONENT DISASSEMBLY | 20 | 515 | 0.0001554 | 0.009732 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RIBONUCLEOTIDE BINDING | 78 | 1860 | 1.089e-16 | 7.23e-14 |
2 | ADENYL NUCLEOTIDE BINDING | 69 | 1514 | 1.557e-16 | 7.23e-14 |
3 | MICROTUBULE MOTOR ACTIVITY | 17 | 77 | 2.115e-15 | 6.549e-13 |
4 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 58 | 1199 | 5.062e-15 | 1.176e-12 |
5 | MACROMOLECULAR COMPLEX BINDING | 61 | 1399 | 9.366e-14 | 1.74e-11 |
6 | HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 45 | 820 | 1.151e-13 | 1.782e-11 |
7 | MOTOR ACTIVITY | 19 | 131 | 1.565e-13 | 2.077e-11 |
8 | ATPASE ACTIVITY | 31 | 427 | 8.832e-13 | 1.026e-10 |
9 | DOUBLE STRANDED DNA BINDING | 41 | 764 | 3.273e-12 | 3.379e-10 |
10 | MICROTUBULE BINDING | 20 | 201 | 4.428e-11 | 4.113e-09 |
11 | SEQUENCE SPECIFIC DNA BINDING | 46 | 1037 | 9.363e-11 | 7.907e-09 |
12 | TUBULIN BINDING | 22 | 273 | 2.868e-10 | 2.221e-08 |
13 | PROTEIN COMPLEX BINDING | 42 | 935 | 4.647e-10 | 3.321e-08 |
14 | CORE PROMOTER PROXIMAL REGION DNA BINDING | 25 | 371 | 7.487e-10 | 4.968e-08 |
15 | ATP DEPENDENT MICROTUBULE MOTOR ACTIVITY | 7 | 18 | 5.281e-09 | 3.271e-07 |
16 | CHROMATIN BINDING | 24 | 435 | 7.822e-08 | 4.541e-06 |
17 | CYTOSKELETAL PROTEIN BINDING | 34 | 819 | 1.612e-07 | 8.809e-06 |
18 | REGULATORY REGION NUCLEIC ACID BINDING | 33 | 818 | 4.74e-07 | 2.446e-05 |
19 | STRUCTURE SPECIFIC DNA BINDING | 11 | 118 | 2.143e-06 | 0.0001048 |
20 | HELICASE ACTIVITY | 12 | 153 | 4.581e-06 | 0.0002128 |
21 | DAMAGED DNA BINDING | 8 | 63 | 5.363e-06 | 0.0002333 |
22 | NUCLEOSOMAL DNA BINDING | 6 | 30 | 5.525e-06 | 0.0002333 |
23 | DNA HELICASE ACTIVITY | 7 | 53 | 1.612e-05 | 0.0006511 |
24 | HISTONE BINDING | 12 | 177 | 2.017e-05 | 0.0007806 |
25 | MISMATCHED DNA BINDING | 4 | 12 | 2.477e-05 | 0.0009204 |
26 | NUCLEOSOME BINDING | 6 | 45 | 6.242e-05 | 0.002148 |
27 | RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC DNA BINDING | 7 | 65 | 6.218e-05 | 0.002148 |
28 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 445 | 6.65e-05 | 0.002206 |
29 | ENHANCER BINDING | 8 | 93 | 9.463e-05 | 0.003031 |
30 | PROTEIN KINASE ACTIVITY | 23 | 640 | 0.0001589 | 0.004919 |
31 | DNA DEPENDENT ATPASE ACTIVITY | 7 | 79 | 0.0002155 | 0.006459 |
32 | CHROMATIN DNA BINDING | 7 | 80 | 0.0002331 | 0.006768 |
33 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 30 | 992 | 0.0003429 | 0.009653 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | KINESIN COMPLEX | 18 | 55 | 1.244e-19 | 7.266e-17 |
2 | MICROTUBULE CYTOSKELETON | 52 | 1068 | 1.282e-13 | 2.496e-11 |
3 | MICROTUBULE ASSOCIATED COMPLEX | 20 | 145 | 9.43e-14 | 2.496e-11 |
4 | CYTOSKELETAL PART | 56 | 1436 | 9.355e-11 | 1.366e-08 |
5 | NUCLEAR CHROMOSOME | 31 | 523 | 1.566e-10 | 1.829e-08 |
6 | CHROMOSOME | 41 | 880 | 2.586e-10 | 2.517e-08 |
7 | SWI SNF SUPERFAMILY TYPE COMPLEX | 12 | 71 | 8.175e-10 | 6.171e-08 |
8 | SPINDLE | 22 | 289 | 8.453e-10 | 6.171e-08 |
9 | MICROTUBULE | 26 | 405 | 9.522e-10 | 6.179e-08 |
10 | MICROTUBULE ORGANIZING CENTER | 32 | 623 | 2.756e-09 | 1.609e-07 |
11 | CYTOSKELETON | 62 | 1967 | 3.4e-08 | 1.805e-06 |
12 | CENTROSOME | 26 | 487 | 4.258e-08 | 2.072e-06 |
13 | MITOTIC SPINDLE | 9 | 55 | 1.481e-07 | 6.651e-06 |
14 | SUPRAMOLECULAR FIBER | 30 | 670 | 1.844e-07 | 7.693e-06 |
15 | MIDBODY | 12 | 132 | 9.655e-07 | 3.759e-05 |
16 | NUCLEOPLASM PART | 29 | 708 | 1.812e-06 | 6.615e-05 |
17 | TRANSFERASE COMPLEX | 28 | 703 | 4.681e-06 | 0.0001608 |
18 | CHROMATIN | 21 | 441 | 5.358e-06 | 0.0001738 |
19 | NUCLEAR CHROMATIN | 16 | 291 | 1.254e-05 | 0.0003855 |
20 | CONDENSED CHROMOSOME OUTER KINETOCHORE | 4 | 12 | 2.477e-05 | 0.0006888 |
21 | ACETYLTRANSFERASE COMPLEX | 9 | 100 | 2.418e-05 | 0.0006888 |
22 | SPINDLE MICROTUBULE | 7 | 58 | 2.944e-05 | 0.0007815 |
23 | SPINDLE MIDZONE | 5 | 27 | 5.125e-05 | 0.001301 |
24 | NUCLEOLUS | 29 | 848 | 5.373e-05 | 0.001307 |
25 | CHROMOSOMAL REGION | 16 | 330 | 5.764e-05 | 0.001346 |
26 | TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 13 | 237 | 8.37e-05 | 0.00188 |
27 | RNA POLYMERASE COMPLEX | 9 | 122 | 0.0001154 | 0.002324 |
28 | CHD TYPE COMPLEX | 4 | 17 | 0.000112 | 0.002324 |
29 | NUCLEAR PERIPHERY | 9 | 121 | 0.0001084 | 0.002324 |
30 | CATALYTIC COMPLEX | 32 | 1038 | 0.0001535 | 0.002988 |
31 | H4 HISTONE ACETYLTRANSFERASE COMPLEX | 4 | 19 | 0.0001781 | 0.003355 |
32 | INO80 TYPE COMPLEX | 4 | 21 | 0.0002684 | 0.004898 |
33 | NUCLEAR REPLICATION FORK | 5 | 39 | 0.0003142 | 0.005561 |
34 | NUCLEAR TRANSCRIPTIONAL REPRESSOR COMPLEX | 4 | 22 | 0.0003241 | 0.005567 |
35 | BAF TYPE COMPLEX | 4 | 23 | 0.0003876 | 0.006467 |
36 | METHYLTRANSFERASE COMPLEX | 7 | 90 | 0.0004811 | 0.007805 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Cell_cycle_hsa04110 | 13 | 124 | 6.326e-08 | 3.29e-06 | |
2 | Oocyte_meiosis_hsa04114 | 8 | 124 | 0.0006788 | 0.01765 | |
3 | Cellular_senescence_hsa04218 | 8 | 160 | 0.003424 | 0.05148 | |
4 | p53_signaling_pathway_hsa04115 | 5 | 68 | 0.00396 | 0.05148 | |
5 | Tight_junction_hsa04530 | 7 | 170 | 0.01645 | 0.1435 | |
6 | FoxO_signaling_pathway_hsa04068 | 6 | 132 | 0.01655 | 0.1435 | |
7 | Notch_signaling_pathway_hsa04330 | 3 | 48 | 0.03761 | 0.2794 | |
8 | Gap_junction_hsa04540 | 4 | 88 | 0.04705 | 0.3058 | |
9 | VEGF_signaling_pathway_hsa04370 | 3 | 59 | 0.06259 | 0.3578 | |
10 | HIF_1_signaling_pathway_hsa04066 | 4 | 100 | 0.0688 | 0.3578 | |
11 | Hippo_signaling_pathway_hsa04390 | 5 | 154 | 0.09 | 0.4255 | |
12 | Hedgehog_signaling_pathway_hsa04340 | 2 | 47 | 0.1632 | 0.6211 | |
13 | Apoptosis_hsa04210 | 4 | 138 | 0.1642 | 0.6211 | |
14 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 4 | 139 | 0.1672 | 0.6211 | |
15 | Sphingolipid_signaling_pathway_hsa04071 | 3 | 118 | 0.2734 | 0.9479 | |
16 | Adherens_junction_hsa04520 | 2 | 72 | 0.3046 | 0.9702 | |
17 | Endocytosis_hsa04144 | 5 | 244 | 0.3232 | 0.9702 | |
18 | Peroxisome_hsa04146 | 2 | 83 | 0.3664 | 0.9702 | |
19 | TGF_beta_signaling_pathway_hsa04350 | 2 | 84 | 0.3719 | 0.9702 | |
20 | Phospholipase_D_signaling_pathway_hsa04072 | 3 | 146 | 0.391 | 0.9702 | |
21 | Rap1_signaling_pathway_hsa04015 | 4 | 206 | 0.3918 | 0.9702 | |
22 | PI3K_Akt_signaling_pathway_hsa04151 | 6 | 352 | 0.4586 | 1 | |
23 | cGMP_PKG_signaling_pathway_hsa04022 | 3 | 163 | 0.4603 | 1 | |
24 | Calcium_signaling_pathway_hsa04020 | 3 | 182 | 0.5336 | 1 | |
25 | Focal_adhesion_hsa04510 | 3 | 199 | 0.5941 | 1 | |
26 | Regulation_of_actin_cytoskeleton_hsa04810 | 3 | 208 | 0.624 | 1 | |
27 | Apelin_signaling_pathway_hsa04371 | 2 | 137 | 0.6261 | 1 | |
28 | Wnt_signaling_pathway_hsa04310 | 2 | 146 | 0.6605 | 1 | |
29 | MAPK_signaling_pathway_hsa04010 | 4 | 295 | 0.6688 | 1 | |
30 | mTOR_signaling_pathway_hsa04150 | 2 | 151 | 0.6784 | 1 | |
31 | Necroptosis_hsa04217 | 2 | 164 | 0.7216 | 1 | |
32 | Ras_signaling_pathway_hsa04014 | 2 | 232 | 0.8751 | 1 | |
33 | Neuroactive_ligand_receptor_interaction_hsa04080 | 2 | 278 | 0.9298 | 1 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | MIR143HG | hsa-miR-107;hsa-miR-129-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-342-5p;hsa-miR-34c-5p;hsa-miR-3614-5p;hsa-miR-491-5p;hsa-miR-590-5p | 10 | MYH11 | Sponge network | -4.237 | 0 | -6.469 | 0 | 0.835 |
2 | HAND2-AS1 | hsa-miR-107;hsa-miR-129-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-342-5p;hsa-miR-34c-5p;hsa-miR-3614-5p;hsa-miR-421;hsa-miR-491-5p | 10 | MYH11 | Sponge network | -5.605 | 0 | -6.469 | 0 | 0.764 |
3 | ADAMTS9-AS1 | hsa-miR-107;hsa-miR-129-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-34c-5p;hsa-miR-3614-5p;hsa-miR-421;hsa-miR-491-5p;hsa-miR-590-5p | 10 | MYH11 | Sponge network | -7.614 | 0 | -6.469 | 0 | 0.761 |
4 | FENDRR | hsa-miR-107;hsa-miR-129-5p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-342-5p;hsa-miR-34c-5p;hsa-miR-3614-5p;hsa-miR-421 | 10 | MYH11 | Sponge network | -4.793 | 0 | -6.469 | 0 | 0.745 |
5 | RP11-887P2.5 | hsa-miR-107;hsa-miR-129-5p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-34c-5p;hsa-miR-3614-5p;hsa-miR-421;hsa-miR-590-5p | 10 | MYH11 | Sponge network | -6.751 | 0 | -6.469 | 0 | 0.662 |
6 | PART1 | hsa-miR-107;hsa-miR-129-5p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-342-5p;hsa-miR-34c-5p;hsa-miR-3614-5p;hsa-miR-491-5p;hsa-miR-590-5p | 11 | MYH11 | Sponge network | -3.06 | 7.0E-5 | -6.469 | 0 | 0.376 |
7 | SNHG14 | hsa-miR-107;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-342-5p;hsa-miR-34c-5p;hsa-miR-3614-5p;hsa-miR-421;hsa-miR-590-5p | 10 | MYH11 | Sponge network | -2.055 | 0 | -6.469 | 0 | 0.351 |
8 | TPTEP1 | hsa-miR-107;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-342-5p;hsa-miR-34c-5p;hsa-miR-3614-5p;hsa-miR-421;hsa-miR-590-5p | 10 | MYH11 | Sponge network | -2.267 | 2.0E-5 | -6.469 | 0 | 0.279 |